Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in in vivo preclinical models of hematopoietic reconstitution and severe colitis Letter

Diaz de la Guardia, Rafael, Lopez-Millan, Belen, Roca-Ho, Heleia et al. (2019). Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in in vivo preclinical models of hematopoietic reconstitution and severe colitis . 104(2), E54-E58. 10.3324/haematol.2018.196568

Open Access International Collaboration

cited authors

  • Diaz de la Guardia, Rafael; Lopez-Millan, Belen; Roca-Ho, Heleia; Bueno, Clara; Gutierrez-Aguera, Francisco; Luis Fuster, Jose; Anguita, Eduardo; Romina Zanetti, Samanta; Vives, Susana; Nomdedeu, Josep; Sackstein, Robert; Lavoie, Jessie; Gonzalez-Rey, Elena; Delgado, Mario; Rosu-Myles, Michael; Menendez, Pablo

sustainable development goals

authors

publication date

  • February 1, 2019

webpage

keywords

  • Hematology
  • Life Sciences & Biomedicine
  • STEM-CELLS
  • STROMAL CELLS
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • FERRATA STORTI FOUNDATION

start page

  • E54

end page

  • E58

volume

  • 104

issue

  • 2